Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year
By Adam Feuerstein
Jan 12, 2015 9:47 AM EST
PRESS RELEASES
Avidity Biosciences Announces Changes To Its Board Of Directors
By PR Newswire
Jan 11, 2021 8:30 AM EST
PRESS RELEASES
Avidity Biosciences Announces 2021 Pipeline Updates And Research Collaboration With MyoKardia
By PR Newswire
Jan 8, 2021 8:30 AM EST
PRESS RELEASES
Avidity Biosciences To Present At The 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Dec 22, 2020 4:05 PM EST
PRESS RELEASES
Avidity Biosciences Announces Addition To The Nasdaq Biotechnology Index
By PR Newswire
Dec 21, 2020 4:05 PM EST
PRESS RELEASES
Avidity Biosciences To Present At The Credit Suisse 29th Annual Virtual Healthcare Conference 2020
By PR Newswire
Nov 5, 2020 4:05 PM EST
PRESS RELEASES
Avidity Biosciences To Present At The Virtual Chardan 4th Annual Genetic Medicines Conference 2020
By PR Newswire
Sep 28, 2020 4:05 PM EDT
PRESS RELEASES
Avidity Biosciences To Present At Several Upcoming Virtual Scientific Meetings
By PR Newswire
Sep 14, 2020 4:05 PM EDT
PRESS RELEASES
Avidity Biosciences To Present At The 2020 Wells Fargo Virtual Healthcare Conference
By PR Newswire
Sep 3, 2020 4:05 PM EDT
PRESS RELEASES
Avidity Biosciences Appoints Jae Kim, M.D. As Chief Medical Officer
By PR Newswire
Jul 27, 2020 8:00 AM EDT
PRESS RELEASES
Avidity Biosciences Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares
By PR Newswire
Jun 16, 2020 4:01 PM EDT
STOCKS
Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year
By Adam Feuerstein
Jan 12, 2015 9:47 AM EST
STOCKS
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
By Adam Feuerstein
Jan 8, 2015 1:09 PM EST
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
By Scott Rutt
Jan 6, 2015 8:25 PM EST
STOCKS
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
By Adam Feuerstein
Dec 17, 2014 9:20 AM EST
MARKETS
Prosensa Holding (RNA) Upgraded From Sell to Hold
By TheStreet Quant Ratings
Dec 12, 2014 7:10 AM EST
STOCKS
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
By Adam Feuerstein
Dec 12, 2014 6:05 AM EST
STOCKS
Jim Cramer's Five Best Stock Picks for the Biotech Sector
By Laurie Kulikowski
Dec 2, 2014 11:11 AM EST
MARKETS
Prosensa (RNA) Highlighted As Today's Perilous Reversal Stock
By Scott Olson
Nov 28, 2014 9:52 AM EST
MARKETS
S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth
By Keris Alison Lahiff
Nov 24, 2014 4:17 PM EST
MARKETS
S&P 500 Holds at Record Highs as Global Optimism Gives Support
By Keris Alison Lahiff
Nov 24, 2014 3:05 PM EST
MARKETS
U.S. Stocks Kick Off Thanksgiving Week Rally Amid Global Optimism
By Keris Alison Lahiff
Nov 24, 2014 10:36 AM EST
STOCKS
November 24 Premarket Briefing: 10 Things You Should Know
By Joseph Woelfel
Nov 24, 2014 6:58 AM EST
STOCKS
BioMarin Expands Reach by Buying Prosensa for Up to $840 Million
By Adam Feuerstein
Nov 24, 2014 6:34 AM EST
STOCKS
Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx
By Adam Feuerstein
Oct 31, 2014 6:40 AM EDT
